Wanbury Balance Sheet Annual

Trade

BSE: 524212 | NSE: WANBURY | ISIN: INE107F01022 | Sector: Biotechnology & Drugs

223.10 +4.35 (1.99%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	2.50	2.44	2.79	1.70
Cash Equivalents	3.40	1.49	22.53	10.00
Short Term Investments	0.92	0.87	1.15	0.61
Cashand Short Term Investments	6.81	4.80	26.46	12.31
Accounts Receivable- Trade Net	89.44	67.98	62.80	34.47
Total Receivables Net	89.44	67.98	62.80	34.47
Total Inventory	36.02	21.99	49.73	24.85
Other Current Assets Total	27.01	27.39	32.25	25.90
Total Current Assets	159.29	122.16	171.24	97.53
Property/ Plant/ Equipment Total- Net	169.56	168.63	169.36	178.17
Intangibles Net	0.27	0.09	0.10	0.23
Long Term Investments	6.94	4.23	3.77	0.38
Note Receivable- Long Term	1.13	-	-	3.10
Other Long Term Assets Total	6.31	8.77	8.08	9.76
Total Assets	343.49	303.87	352.55	289.18
Accounts Payable	162.75	148.47	191.61	133.77
Notes Payable/ Short Term Debt	27.95	13.19	13.21	16.42
Current Portof LT Debt/ Capital Leases	2.60	52.70	56.27	42.71
Other Currentliabilities Total	20.80	106.02	98.69	162.46
Total Current Liabilities	214.11	320.38	359.77	355.35
Long Term Debt	82.00	0.00	0.00	71.99
Capital Lease Obligations	3.93	2.38	4.13	4.32
Total Long Term Debt	85.93	2.38	4.13	76.32
Total Debt	116.48	68.27	73.60	135.44
Other Liabilities Total	15.51	13.93	12.07	13.75
Total Liabilities	315.55	336.69	375.97	445.42
Common Stock Total	32.75	32.71	32.67	25.02
Retained Earnings( Accumulated Deficit)	-4.80	-65.52	-56.09	-181.26
Total Equity	27.94	-32.82	-23.42	-156.24
Total Liabilities Shareholders' Equity	343.49	303.87	352.55	289.18
Total Common Shares Outstanding	3.27	3.27	3.27	2.50
Tangible Book Valueper Share Common Eq	8.45	-10.06	-7.20	-62.55